Global and United States Latent TB Infection Testing Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Latent TB Infection Testing Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Latent TB Infection Testing Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Latent TB Infection Testing Market Size for the Year 2017-2028
  • 1.2.2 Global Latent TB Infection Testing Market Size for the Year 2017-2028
• 1.3 Latent TB Infection Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Latent TB Infection Testing in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Latent TB Infection Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Latent TB Infection Testing Market Dynamics
  • 1.4.1 Latent TB Infection Testing Industry Trends
  • 1.4.2 Latent TB Infection Testing Market Drivers
  • 1.4.3 Latent TB Infection Testing Market Challenges
  • 1.4.4 Latent TB Infection Testing Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Latent TB Infection Testing by Type

• 2.1 Latent TB Infection Testing Market Segment by Type
  • 2.1.1 Mantoux Test / Tuberculin Skin Test (TST)
  • 2.1.2 Interferon-Gamma Release Assay (IGRA)
• 2.2 Global Latent TB Infection Testing Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Latent TB Infection Testing Market Size by Type (2017-2028)
• 2.4 United States Latent TB Infection Testing Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Latent TB Infection Testing Market Size by Type (2017-2028)

3 Latent TB Infection Testing by Application

• 3.1 Latent TB Infection Testing Market Segment by Application
  • 3.1.1 Hospitals
  • 3.1.2 Public and Student Health
  • 3.1.3 Physician Offices and Clinics
  • 3.1.4 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
• 3.2 Global Latent TB Infection Testing Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Latent TB Infection Testing Market Size by Application (2017-2028)
• 3.4 United States Latent TB Infection Testing Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Latent TB Infection Testing Market Size by Application (2017-2028)

4 Global Latent TB Infection Testing Competitor Landscape by Company

• 4.1 Global Latent TB Infection Testing Market Size by Company
  • 4.1.1 Top Global Latent TB Infection Testing Companies Ranked by Revenue (2021)
  • 4.1.2 Global Latent TB Infection Testing Revenue by Player (2017-2022)
• 4.2 Global Latent TB Infection Testing Concentration Ratio (CR)
  • 4.2.1 Latent TB Infection Testing Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Latent TB Infection Testing in 2021
  • 4.2.3 Global Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Latent TB Infection Testing Headquarters, Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Latent TB Infection Testing Headquarters and Area Served
  • 4.3.2 Global Latent TB Infection Testing Companies Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Latent TB Infection Testing Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Latent TB Infection Testing Market Size by Company
  • 4.5.1 Top Latent TB Infection Testing Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Latent TB Infection Testing Revenue by Players (2020, 2021 & 2022)

5 Global Latent TB Infection Testing Market Size by Region

• 5.1 Global Latent TB Infection Testing Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Latent TB Infection Testing Market Size by Region (2017-2028)
  • 5.2.1 Global Latent TB Infection Testing Market Size by Region: 2017-2022
  • 5.2.2 Global Latent TB Infection Testing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Latent TB Infection Testing Market Size YoY Growth 2017-2028
  • 6.1.2 North America Latent TB Infection Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Latent TB Infection Testing Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Latent TB Infection Testing Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Latent TB Infection Testing Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Latent TB Infection Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Latent TB Infection Testing Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Latent TB Infection Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Latent TB Infection Testing Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Latent TB Infection Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
  • 7.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
  • 7.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
  • 7.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Introduction
  • 7.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Development
• 7.2 Pharmstandard (Generium Pharmaceutical)
  • 7.2.1 Pharmstandard (Generium Pharmaceutical) Company Details
  • 7.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
  • 7.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Introduction
  • 7.2.4 Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.2.5 Pharmstandard (Generium Pharmaceutical) Recent Development
• 7.3 Sanofi S.A./Sanofi Pasteur Ltd.
  • 7.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Details
  • 7.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
  • 7.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Introduction
  • 7.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Development
• 7.4 Statens Serum Institut (SSI)
  • 7.4.1 Statens Serum Institut (SSI) Company Details
  • 7.4.2 Statens Serum Institut (SSI) Business Overview
  • 7.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Introduction
  • 7.4.4 Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.4.5 Statens Serum Institut (SSI) Recent Development
• 7.5 Autoimmun Diagnostika (AID) GmbH
  • 7.5.1 Autoimmun Diagnostika (AID) GmbH Company Details
  • 7.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
  • 7.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Introduction
  • 7.5.4 Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.5.5 Autoimmun Diagnostika (AID) GmbH Recent Development
• 7.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
  • 7.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
  • 7.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
  • 7.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Introduction
  • 7.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Development
• 7.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
  • 7.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
  • 7.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
  • 7.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Introduction
  • 7.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Development
• 7.8 Immunoshop India Pvt. Ltd.
  • 7.8.1 Immunoshop India Pvt. Ltd. Company Details
  • 7.8.2 Immunoshop India Pvt. Ltd. Business Overview
  • 7.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Introduction
  • 7.8.4 Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.8.5 Immunoshop India Pvt. Ltd. Recent Development
• 7.9 Qiagen N.V.
  • 7.9.1 Qiagen N.V. Company Details
  • 7.9.2 Qiagen N.V. Business Overview
  • 7.9.3 Qiagen N.V. Latent TB Infection Testing Introduction
  • 7.9.4 Qiagen N.V. Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.9.5 Qiagen N.V. Recent Development
• 7.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
  • 7.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
  • 7.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
  • 7.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Introduction
  • 7.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Development
• 7.11 SD Biosensor, Inc.
  • 7.11.1 SD Biosensor, Inc. Company Details
  • 7.11.2 SD Biosensor, Inc. Business Overview
  • 7.11.3 SD Biosensor, Inc. Latent TB Infection Testing Introduction
  • 7.11.4 SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2017-2022)
  • 7.11.5 SD Biosensor, Inc. Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details